Russian HIV vaccine in clinical trials; Medicago invests $4 million in Quebec;

> An HIV vaccine has completed its first clinical trial in Russia, at the State Research Center for Virology and Biotechnology (Vektor). Article

> Biotech vaccine company Medicago is planning to invest $4 million to enhance the capacity of its pilot production facility in Quebec City. Press release

> DCPrime has received orphan drug designation for its therapeutic cell-based cancer vaccine in development for the treatment of acute myeloid leukemia. Press release

> The Institute of Human Virology, Nigeria predicts an HIV vaccine within the next 5 years. News

> Soligenix's proprietary vaccine thermostabilization technology has passed through its preclinical proof-of-concept studies and can keep vaccine formulations stable without refrigeration. Press release

> The prostate cancer vaccine Provenge could be useful in early-stage cancer, according to a study at UCSF. Article

> The UN is backing a mass yellow fever vaccination campaign in northern Cameroon following an outbreak of deaths from the disease. News

> Pediatricians recommend a 'cocoon' strategy--vaccinating the whole family to protect babies. Item

> Vaccines do not lead to Guillain-Barré syndrome. Story

And Finally... The NIH is looking to fund the preclinical development of technologies to improve vaccine effectiveness and/or simplify vaccine delivery. Funding opportunity announcement

Suggested Articles

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.